Friday, March 31, 2023
Clinical Advances in
Read Overview
Supported by an independent educational grant from
Sunovion Pharmaceuticals Inc.
Steering Committee Chair
Adelaide Lackner Professor and Chair of Neurology
Executive Director, Norman Fixel Institute for Neurological Diseases
University of Florida Health
Gainesville, Florida
Steering Committee Member
Associate Professor of Neurology
Vanderbilt University Medical Center
Nashville, Tennessee
Steering Committee Member
Clinical Associate Professor of Neurology
University of Southern California
Keck School of Medicine of USC
Co-Director, DBS Program
Program Director, Neurology Residency
Los Angeles, California
Steering Committee Member
Associate Professor of Neurology
Florida International University
Herbert Wertheim College of Medicine
Miami, Florida, United States
Director of the Parkinson’s Disease and Movement Disorders Center
Boca Raton, Florida
Steering Committee Member
Associate Professor of Neurology
Vice-Chair of Education
Co-Director of the Comprehensive Parkinson’s Disease and Movement Disorders Center at the Farber Institute for Neuroscience
Sidney Kimmel Medical College
Jefferson University
Philadelphia, Pennsylvania
Steering Committee Member
Carlin and Ellen Wiegner Endowed Professor of Neurology
Medical Director and Division Chief
UCSF Movement Disorders and Neuromodulation Center
Weill Institute for Neuroscience
University of California San Francisco
San Francisco, California
Steering Committee Chair
Has disclosed no relevant financial relationships.
Steering Committee Member
Has disclosed the following relevant financial relationships:
Served as an advisor or consultant for: Alterity; Wave Life Sciences
Received grants for clinical research from: AbbVie; Alterity; Genentech; Huntington Study Group; Neurocrine; Roche; Wave Life Sciences
Steering Committee Member
Has disclosed the following relevant financial relationships:
Served as an advisor or consultant for: Acorda; Sunovion
Served as a speaker or a member of a speakers bureau for: Sunovion
Received grants for clinical research from: Roche
Steering Committee Member
Has disclosed the following relevant financial relationships:
Served as an advisor or consultant for: AbbVie; Acadia; Acorda; Adamas; Addex; Allergan; Amneal; Brittania; CENTOGENE; Cerecor; GE Healthcare; Global Kinetics; Kyowa Kirin; Lundbeck; Merz; KeifeRx; Neurocrine; NeuroDerm; Pharma2B; Revance; Sunovion; Supernus; Teva; UCB
Served as a speaker or a member of a speakers bureau for: AbbVie; Acadia; Acorda; Adamas; Allergan; Amneal; GE Healthcare; Kyowa Kirin; Lundbeck; Neurocrine; Sunovion; Supernus; Teva
Received grants for clinical research from: AbbVie; Acadia; Acorda; Adamas; Addex; Amneal; Aptinyx; Axial; Benevolent; Biogen; Biohaven; Brittania; Cala; Cerecor; CENTOGENE; Cerevance; Cerevel; Chase; Enterin; Global Kinetics; Jazz; Kyowa Kirin; Lilly USA, LLC; Lundbeck; Neurocrine; NeuroDerm; Pharma2B; Revance; Roche; Sanofi; Sun Pharma; Sunovion; Supernus; Teva; Theravance; UCB
Steering Committee Member
Has disclosed no relevant financial relationships.
Steering Committee Member
Has disclosed the following relevant financial relationships:
Served as an advisor or consultant for: Abbott
Received grants for clinical research from: Biogen; Boston Scientific; Medtronic; NeuroDerm; Roche; Rune
